Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways

Discover the intricate world of cancer treatment resistance with "Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways" by Yosef Yarden. Published by Springer Nature Switzerland AG in 2019, this informative softcover edition spans 242 pages, delivering a thorough examination of the diverse mechanisms contributing to patient resistance against modern anti-cancer medications, including tyrosine kinase inhibitors and monoclonal antibodies.

Yarden expertly unravels the complexities of growth factor receptor blockers and their crucial roles in cancer progression, providing readers with a nuanced understanding of both the challenges and advancements in oncology. This volume is an essential resource for researchers, clinicians, and students alike who are looking to deepen their knowledge of resistance mechanisms and enhance their approach to cancer therapies. Get your copy today and stay at the forefront of cancer research!